Psychiatry and Behavioral Sciences
Showing 1-54 of 54 Results
-
Kate Dahl, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Kate Dahl specializes in working with children and families who are affected by medical illness. She has practiced at Stanford since 2014 and is the primary pediatric psychologist for the kidney transplant team. She also serves as the Director of the Medical Coping and Wellness Clinic in Child Psychiatry. Her work focuses on adjustment to new diagnosis, coping with illness and treatment, and adherence to the medical regimen. Dr. Dahl is particularly interested in the experience of adolescents with chronic medical conditions and leads groups for teens who have received kidney transplants.
-
Francesco Nandkumar Dandekar
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Dandekar is a Clinical Associate Professor and Associate Director of Sports Psychiatry at Stanford University. After graduating summa cum laude from the University of Southern California with a B.S. in Biomedical Engineering, he earned a Regents Scholarship to complete his M.D. at UC San Diego, where he received the American Academy of Neurology’s Prize for Excellence. During his residency and fellowship at Stanford, Dr. Dandekar provided care to a variety of patients utilizing a combination of medication management, psychotherapy, and lifestyle changes (sleep, nutrition, exercise, recovery). Teamed with Clinical Professor Dr. Douglas Noordsy, he helped to incorporate psychiatric services into Stanford's sports psychology program, and continues to see elite athletes as part of the Stanford Sports Psychiatry Clinic. He also specializes in treating physicians, and sees many residents, fellows, and attendings in his private practice. In his free time, he enjoys playing tennis, chess, and guitar.
-
Beth Darnall, PhD
Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Psychiatry and Behavioral Sciences (General Psychiatry & Psychology (Adult))
Current Research and Scholarly InterestsThe Stanford Pain Relief Innovations Lab is dedicated to better characterizing and treating pain with patient-centered solutions. We specialize in the conduct of large-scale acute and chronic pain clinical trials that aim to (1) expand and scale access to behavioral medicine via digital and brief treatments; (2) reduce opioid risks via reduction for some and improved opioid access for others; (3) equip healthcare providers with brief behavioral medicine interventions to optimize health outcomes.
-
Smita Das
Clinical Professor, Psychiatry and Behavioral Sciences
BioSmita Das, MD, PhD, MPH is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. Dr. Das studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She completed psychiatry residency and was chief resident at Stanford followed by an addiction psychiatry fellowship at UCSF. She has over 2 decades of experience in research in healthcare quality and addiction. Dr. Das is a former chair of the APA Council on Addiction Psychiatry, a past president an APA District Branch and is on the Advisory Council for Workplace Mental Health at the APA. Dr. Das was Director of Addiction Treatment Services at the Palo Alto VA. Currently Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Associate Professor and is also at a mental health start-up.
-
Sallie De Golia
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is Director of Coaching and Senior Faculty Educational Consultant in Stanford's Department of Psychiatry and Behavioral Sciences. She is a Peer Teaching Coach and Fellow in the Stanford Teaching and Mentoring Academy, has taught regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.
-
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical and Translational Neurosciences Incubator)
Current Research and Scholarly InterestsMy lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
-
Charles DeBattista
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
On Partial Leave from 10/01/2025 To 10/01/2026Current Research and Scholarly InterestsTreatment resistant depression.
Novel biological interventions in the treatment of mental illness.
Anti-glucocorticoid drugs in the treatment of mood disorders.
Augmentation strategies in the treatment of depression. -
Karl Deisseroth
D. H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsKarl Deisseroth's laboratory created and developed optogenetics, hydrogel-tissue chemistry (beginning with CLARITY), and a broad range of enabling methods. He also has employed his technologies to discover the neural cell types and connections that cause adaptive and maladaptive behaviors.
-
Huiqiong Deng, MD, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Huiqiong Deng is a clinical associate professor of psychiatry. In addition to a medical degree, she earned a PhD, with a major in rehabilitation science and a minor in neuroscience. Specializing in the treatment of alcohol/substance addiction, interventional and cultural psychiatry, her goal is to help each patient along the journey to achieve optimal health and quality of life.
As the co-author of more than a dozen scholarly articles, Dr. Deng’s work has appeared in Psychiatry Research, Journal of Studies on Alcohol and Drugs, American Journal on Addictions, Brain Stimulation, and other publications.
Dr. Deng has won numerous honors and awards such as the National Institute on Drug Abuse Young Investigator Travel Award, the Ruth Fox Scholarship from the American Society of Addiction Medicine, and College on the Problems of Drug Dependence Travel Award for Early Career Investigators. In addition, she was selected to attend the Annual American Psychiatry Association Research Colloquium for Junior Investigators. Since she joined faculty at Stanford, Dr. Deng has received research grant support by the Department of Psychiatry and Behavioral Sciences Innovator Grant Program. -
Ana C. DiRago, Ph.D.
Academic Staff - Hourly - CSL, Psychiatry and Behavioral Sciences
BioDr. DiRago is a bilingual (Spanish) licensed clinical psychologist who specializes in diagnostic psychological and neuropsychological evaluations of individuals across the lifespan. In her role as Adjunct Professor, she teaches and supervises fellows in the Stanford Forensic Psychiatry Fellowship Program. She is a member of the Program in Psychiatry and the Law.
-
Jasmine Dobbs-Marsh, PsyD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Jasmine Dobbs-Marsh is a licensed psychologist who specializes in the management of trauma, complex trauma, interpersonal anxiety, mood disorders, identity-related concerns, and relationship conflict. She received her doctorate in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium and her BA with Distinction in Psychology and Political Science from Stanford University. She completed her clinical internship at the UCLA Counseling and Psychological Services and her postdoctoral fellowship at Stanford University’s School of Medicine. She provides psychotherapy and clinical supervision from an intersectional lens. Dr. Dobbs-Marsh currently serves patients through the DBT Clinics at Stanford School of Medicine. She directs the DBT Couple & Family Program, which serves the needs of couples and families experiencing high conflict and persistent problems in relationship interactions. She also provides individual DBT, DBT Skills Group, and specialized care through the DBT-Trauma program.
-
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. With extensive experience in interventional psychiatry, Dr. Bandeira has led multiple clinical trials focused on noninvasive brain stimulation and rapid-acting antidepressants for psychiatric disorders in children, adolescents, and adults. He received the prestigious Professor Alfredo Thomé de Britto Award in recognition of his exceptional research achievements during his physician-scientist training at the Federal University of Bahia in Salvador, Brazil.
As part of his medical training, Dr. Bandeira also studied at the University of Sydney (Australia) on a Science Without Borders Scholarship, where he enhanced his clinical and research skills at the university’s Brain and Mind Centre. Upon returning to Brazil, he gained valuable clinical experience as an attending physician with the Brazilian Ministry of Health and worked on the frontlines during the COVID-19 pandemic.
At Stanford, working with Dr. Nolan R. Williams, Dr. Bandeira led the Wellcome LEAP trial on accelerated intermittent theta-burst stimulation (Stanford Neuromodulation Therapy) to treat anhedonic depression. Alongside Dr. Alan F. Schatzberg, he is co-leading a trial supported by the American Foundation for Suicide Prevention, evaluating the efficacy and safety of buprenorphine in sustaining the antisuicidal effects of ketamine. His work centers on developing personalized therapeutics for treatment-resistant depression, bipolar depression, and suicidal behavior.
Looking ahead, Dr. Bandeira plans to apply for psychiatry residency programs in the United States to advance his career in academic psychiatry and clinical research. -
Shaul Druckmann
Associate Professor of Neurobiology, of Psychiatry and Behavioral Sciences and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsOur research goal is to understand how dynamics in neuronal circuits relate and constrain the representation of information and computations upon it. We adopt three synergistic strategies: First, we analyze neural circuit population recordings to better understand the relation between neural dynamics and behavior, Second, we theoretically explore the types of dynamics that could be associated with particular network computations. Third, we analyze the structural properties of neural circuits.
-
Tianwei Du
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Du's clinical interests focus on providing evidence-based treatment to individuals with emotion dysregulation, interpersonal difficulties, and/or complex trauma. She is also passionate about addressing diversity factors in clinical work. Dr. Du provides services in the Dialectical Behavior Therapy (DBT) Adult Program, Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic, and the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic. Dr. Du is a bilingual clinician speaking English and Mandarin.
Dr. Du's research focuses on exploring the roles of interpersonal processes and personality in psychopathology, and she has published widely on this topic. Dr. Du also participated in a variety of clinical trials to help develop and improve evidence-based interventions for individuals with complex clinical presentations and populations with limited access to mental health care. -
Laramie Duncan
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsOur work is at the intersection of statistical genetics, psychiatry, and neuroscience. We use massive datasets and primarily computational approaches to identify mechanisms contributing to mental health problems like schizophrenia and depression. The overall goal of the lab is to discover fundamental information about psychiatric disorders, and ultimately to build more effective approaches to classification, prevention, and treatment.
-
Timothy Durazzo
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe mission of the Durazzo BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, our multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety. Data from Veteran's Administration and Stanford funded Clinical trials are currently being analyzed by the BRASS lab to evaluate the efficacy of repetitive transcranial magnetic stimulation techniques as novel complementary treatments to reduce the high rate of return to hazardous drinking experienced by individuals with alcohol and substance abuse disorders. The ultimate goal of our multidisciplinary research program is to promote the development of more effective biomedical and behavioral treatments for alcohol and substance use disorders through consideration of the brain biology, psychology and social circumstances of each individual.
